Streetbeat News

Price Targets

WDAY

BMO Capital analyst Daniel Jester has maintained an 'Outperform' rating on Workday (NASDAQ:WDAY) and raised the price target from $240 to $260.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:44 pm

HRB

Goldman Sachs analyst George Kelly maintains a 'Sell' rating on H&R Block (NYSE:HRB) but raises the price target from $28 to $32.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 12:43 pm

LRN

BMO Capital analyst Jeffrey Silber maintains an Outperform rating on Stride (NYSE:LRN) and raises the price target from $49 to $50.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:43 pm

DH

Goldman Sachs analyst Kash Rangan has maintained a Neutral rating on Definitive Healthcare (NASDAQ:DH) and lowered the price target from $17 to $10.5.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 12:42 pm

WOOF

Wedbush analyst Seth Basham maintains an Outperform rating on Petco Health and Wellness (NASDAQ:WOOF) but lowers the price target from $10 to $9.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:39 pm

DKS

Wedbush analyst Seth Basham has reiterated an Outperform rating on Dick's Sporting Goods (NYSE:DKS) and maintained a $155 price target.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:38 pm

VFC

Wedbush analyst Tom Nikic has reiterated a Neutral rating on VF (NYSE:VFC) and maintained a $21 price target.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:37 pm

HD

Wedbush analyst Seth Basham maintains a Neutral rating on Home Depot (NYSE:HD) and raises the price target from $290 to $350.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:36 pm

AGLE

Wells Fargo analyst Yanan Zhu has maintained an Equal-Weight rating on Aeglea BioTherapeutics (NASDAQ:AGLE) and raised the price target from $0.35 to $0.5.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2023 | 12:36 pm

EWTX

Wedbush analyst Laura Chico has reiterated her 'Outperform' rating on Edgewise Therapeutics (NASDAQ:EWTX) and maintained a $27 price target.

Portfolio Pulse from richadhand@benzinga.com

August 16, 2023 | 12:35 pm